Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/208126
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMartino, David J.-
dc.contributor.authorBui, Dinh S.-
dc.contributor.authorLi, Shuai-
dc.contributor.authorIdrose, Sabrina-
dc.contributor.authorPerret, Jennifer-
dc.contributor.authorLowe, Adrian J.-
dc.contributor.authorLodge, Caroline J.-
dc.contributor.authorBowatte, Gayan-
dc.contributor.authorMoodley, Yuben-
dc.contributor.authorThomas, Paul S.-
dc.contributor.authorZosky, Graeme-
dc.contributor.authorHansbro, Philip M.-
dc.contributor.authorHolloway, John W.-
dc.contributor.authorSvanes, Cecilie-
dc.contributor.authorFaner, Rosa-
dc.contributor.authorWalters, Eugene H.-
dc.contributor.authorDharmage, Shyamali C.-
dc.date.accessioned2024-02-27T12:27:02Z-
dc.date.available2024-02-27T12:27:02Z-
dc.date.issued2023-11-15-
dc.identifier.issn1073-449X-
dc.identifier.urihttp://hdl.handle.net/2445/208126-
dc.description.abstractUnderstanding the molecular mechanisms of lung function trajectories that progress to chronic obstructive pulmonary disease (COPD) (pre-COPD trajectories), especially those with a rapidly declining phenotype, should inform preventive interventions. The Tasmanian Longitudinal Health Study (TAHS) previously defined life-course lung function trajectories by serial spirometry in a cohort of all seven-year-old school children in the state of Tasmania recruited in 1968 and followed up to age 53 years (1). Of the six pre-bronchodilator FEV1 lifetime trajectories identified, three collectively accounted for 75% of chronic obstructive pulmonary disease (COPD) prevalence at age 53 years (2). These high-risk trajectories were: 1) early below average lung function (with usual rate of subsequent decline), 2) persistently low, and 3) early below average lung function with accelerated decline. The TAHS cohort provides a unique opportunity to investigate molecular factors associated with disadvantaged trajectories, and we conducted a pilot study in this cohort to characterize associations with COPD high-risk trajectories to inform more extensive longitudinal studies in the future.-
dc.format.extent12 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherAmerican Thoracic Society-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1164/rccm.202306-1025LE-
dc.relation.ispartofAmerican Journal of Respiratory and Critical Care Medicine, 2023, vol. 208, num.10, p. 1135-1137-
dc.relation.urihttps://doi.org/10.1164/rccm.202306-1025LE-
dc.rights(c) American Thoracic Society, 2023-
dc.sourceArticles publicats en revistes (Biomedicina)-
dc.subject.classificationMalalties del pulmó-
dc.subject.classificationGenètica-
dc.subject.classificationEpigènesi-
dc.subject.otherPulmonary diseases-
dc.subject.otherGenetics-
dc.subject.otherEpigenesis-
dc.titleGenetic and Epigenetic Associations with Pre-Chronic Obstructive Pulmonary Disease Lung Function Trajectories-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec744451-
dc.date.updated2024-02-27T12:27:02Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina9380576-
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Biomedicina)

Files in This Item:
File Description SizeFormat 
847529.pdf294.32 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.